CGH
ASND icon

Crossmark Global Holdings’s Ascendis Pharma A/S ASND Stock Holding History

Crossmark Global Holdings’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.78M Buy
7,783
+390
+5% +$87.4K 0.03% 460
2025
Q4 		$1.58M Buy
7,393
+2,499
+51% +$516K 0.02% 490
2025
Q3 		$973K Sell
4,894
-474
-9% -$88.4K 0.01% 637
2025
Q2 		$927K Sell
5,368
-480
-8% -$78.2K 0.02% 644
2025
Q1 		$911K Sell
5,848
-4,587
-44% -$655K 0.02% 644
2024
Q4 		$1.44M Buy
10,435
+2,315
+29% +$304K 0.03% 479
2024
Q3 		$1.21M Buy
+8,120
New +$1.1M 0.02% 544

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return